id: x_waiver_process_complexity_to_buprenorphine_prescribing_rate
name: X-Waiver Process Complexity â†’ Buprenorphine Prescribing Rate
from_node:
  node_id: x_waiver_process_complexity
  node_name: X-Waiver Process Complexity
to_node:
  node_id: buprenorphine_prescribing_rate
  node_name: Buprenorphine Prescribing Rate
direction: negative
category: political
mechanism_pathway:
- 'Step 1: Complex X-waiver regulatory requirements under Drug Addiction Treatment
  Act of 2000 create administrative burden for clinicians'
- 'Step 2: Administrative complexity deters clinicians from completing waiver process
  after training (only 48% obtained waiver)'
- 'Step 3: Among waivered clinicians, perceived complexity continues to impede actual
  prescribing behavior'
- 'Step 4: Reduced clinician participation limits geographic availability and patient
  access to evidence-based opioid use disorder treatment'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: H. Lanham et al. 2022. "Survey of Barriers and Facilitators to
    Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment
    Act of 2000 Waiver." *JAMA Network Open*. https://doi.org/10.1001/jamanetworkopen.2022.12419
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.711519'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: professional_support_networks
  direction: weakens
  strength: strong
  description: Supportive professional networks identified as key facilitator that
    can overcome regulatory complexity barriers
